Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Kadmon kicks off 'real-time' NDA submission with another look at 'remarkable' chronic graft-versus-host-disease data
5 years ago
R&D
Once valued at $4B, an embattled Akorn — nursing a market cap of roughly $37M — files for bankruptcy
5 years ago
Pharma
FDA+
Bezos, Paul Allen funds, a16z put up $100M to build an Illumina of human proteins
5 years ago
Financing
Startups
As CEO bounces back from Covid-19, Apellis says FDA meeting clears path to file for an OK on Soliris rival
5 years ago
R&D
FDA+
HotSpot announces $65M Series B, as Nimbus pioneers look to keep up in a crowding field
5 years ago
R&D
Gilead, Galapagos claim PhIIb/III win for filgotinib in ulcerative colitis — which pales in comparison to rivals
5 years ago
R&D
EMA extends virtual-only meeting policy through August
5 years ago
FDA+
Coronavirus
Covid-19 roundup: BARDA hands AstraZeneca $1B-plus to race through PhIII and ramp up fall deliveries of Oxford’s ...
5 years ago
Coronavirus
Mammoth Biosciences teams with GSK to put Covid-19 CRISPR tests at home, airports, borders
5 years ago
Coronavirus
Covid-19 roundup: Hit with new conflict accusations, Janet Woodcock steps out of the agency's Covid-19 chain of ...
5 years ago
R&D
Coronavirus
Silence Therapeutics wants to list on Nasdaq while pursuing new deals; Surface Oncology inks latest Keytruda ...
5 years ago
News Briefing
Pharmasset co-founder jumps into Covid-19 fight, with a new company and $215 million to get there
5 years ago
Financing
Coronavirus
Andreessen Horowitz backs a new molecule builder from UCLA equipped with the latest in convergence tech. And he’s ...
5 years ago
People
Financing
George Church spinoff swallows a key manufacturing partner as it preps CRISPR-edited pig organs for animal testing
5 years ago
Deals
A little-known biotech running low on cash looks to get its own $100M IPO from pandemic market
5 years ago
Financing
Flush with $165M IPO cash, Zentalis entices Tybourne, OrbiMed to fund a $20M China joint venture
5 years ago
Financing
FDA, Aetion partner on real-world data analytics for Covid-19
5 years ago
FDA+
Coronavirus
AstraZeneca, Merck push blockbuster franchise to another key FDA approval, relegating a rival to second-fiddle status
5 years ago
Pharma
FDA+
Ally Bridge joins Bain in $120M bet that speeding up manufacturing QC can hit big in post-pandemic world
5 years ago
Financing
Outsourcing
How a California biotech briefly tripled its value by hyping a Covid-19 ‘cure’
5 years ago
R&D
Coronavirus
Novartis taps Iya Khalil, physicist co-founder of GNS Healthcare, to lead AI Innovation Center
5 years ago
People
AI
Kintor Pharmaceuticals completes $240 million IPO; WuXi Biologics is opening a Boston plant
5 years ago
News Briefing
'Tis the season for biopharma fundraising, as Cowen closes $493M fund
5 years ago
Financing
BARDA offers a tiny startup up to $812M to create a US-based drug manufacturer — and the CEO comes with a price ...
5 years ago
Startups
Deals
First page
Previous page
825
826
827
828
829
830
831
Next page
Last page